← SynDRA
STANOZOLOL
SynDRA canonical compound SYN0029839 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · OTC |
|---|
| Primary target(s) | AR |
|---|
| Mechanism of action | androgen receptor agonist |
|---|
| Indication | breast cancer |
|---|
| Disease area | Oncology |
|---|
All known targets
- AR
- ADORA3
- Ar
- CYP2C19
- CYP2C9
- CYP2D6
- ESR1
- PGR
Mechanisms of action (all sources)
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- ESR2
- LCK
- MMP1
- MC5R
- MC4R
- MC3R
- MAPK3
- MAPK14
- MAPK1
- MAOA
- KCNH2
- NPY1R
- HTR6
- HTR2C
- HTR2B
- HTR2A
- HRH2
- HRH1
- HMGCR
- HDAC6
- MMP9
- ACHE
- FYN
- PTPRC
- TBXAS1
- TACR2
- TACR1
- SLC6A4
- SLC6A3
- SLC6A2
- SIGMAR1
- SAMHD1
- PTGS2
- NR3C1
- PTGS1
- PTAFR
- PRKCA
- PPP3CA
- PDE5A
- OPRM1
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
- ACM1
- CP2C9
- CP2CJ
- CP2D6
- CP3A4
- CP3A7
- ESRRA
- GLI3
- JUN
- KSYK
- NF2L2
- NR1I2
- PRGR
- SYK
Drug classes
- Anabolic Agents
- Androgens
- Hormones
ATC classes
Cross-references
Synonyms
- WINSTROL
- androstanazol
- androstanazole
- androstanazolestanazol
- estazol
- stanazolol
- tevabolin
- Estanozolol
- Androstanazol
- Androstanazole
- Stanozolol ciii
- Winstrol depot
- NSC-233046
- NSC-43193
- WIN-14833
- Stromba
- Tevabolin
- Winstrol
- Stanazolol
- Winstrol Depot
- Strombaject
- Estazol
- Winstroid
- Anabol
- Winstrol-V
- Stanozololum
- Stanozolo [DCIT]
- Androstanazole (VAN)
- WIN 14833
- Stanozolol (1'H form)
- Stanozololum [INN-Latin]
- Estanozolol [INN-Spanish]
- UNII-4R1VB9P8V3
- Androstanazolestanazol
- HSDB 3185
- Stanozolol (2'H form)
- EINECS 233-894-8
- NSC 43193
Look up STANOZOLOL in the interactive SynDRA portal →